Phase II dose-finding study of SK-0403 with type 2 diabetes mellitus.
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2008
At a glance
- Drugs Anagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 09 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Oct 2007 New trial record.